ciprofloxacin has been researched along with Trypanosomiasis, African in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human African trypanosomiasis (HAT) or sleeping sickness is caused by two subspecies of Trypanosoma brucei , Trypanosoma brucei gambiense , and Trypanosoma brucei rhodesiense and is one of Africa's old plagues." | 1.38 | Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei. ( Braunschweig, H; Damme, A; Engstler, M; Hiltensperger, G; Holzgrabe, U; Jones, NG; Jung, J; Kaiser, M; Meinel, L; Niedermeier, S; Puhl, S; Stich, A, 2012) |
| "Furthermore, opportunistic secondary bacterial infection during trypanosomosis did not seem to play an important role in the changes in plasma LBP levels." | 1.35 | Lipopolysaccharide binding protein in the acute phase response of experimental murine Trypanosoma brucei brucei infection. ( Burke, J; Eckersall, PD; Jennings, FW; Mburu, JN; Mungatana, NK; Murray, M; Ngure, RM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiltensperger, G | 1 |
| Jones, NG | 1 |
| Niedermeier, S | 1 |
| Stich, A | 1 |
| Kaiser, M | 1 |
| Jung, J | 1 |
| Puhl, S | 1 |
| Damme, A | 1 |
| Braunschweig, H | 1 |
| Meinel, L | 1 |
| Engstler, M | 1 |
| Holzgrabe, U | 1 |
| Pomel, S | 1 |
| Dubar, F | 1 |
| Forge, D | 1 |
| Loiseau, PM | 1 |
| Biot, C | 1 |
| Ngure, RM | 1 |
| Eckersall, PD | 2 |
| Mungatana, NK | 1 |
| Mburu, JN | 1 |
| Jennings, FW | 2 |
| Burke, J | 2 |
| Murray, M | 2 |
| Ngure, R | 1 |
| Mbai, FN | 1 |
4 other studies available for ciprofloxacin and Trypanosomiasis, African
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Topics: Acute Disease; Animals; Cell Line; DNA Topoisomerases, Type II; DNA, Kinetoplast; Mice; Microscopy, | 2012 |
New heterocyclic compounds: Synthesis and antitrypanosomal properties.
Topics: Aminoquinolines; Animals; Benzimidazoles; Cell Line; Ferrous Compounds; Halogenation; Heterocyclic C | 2015 |
Lipopolysaccharide binding protein in the acute phase response of experimental murine Trypanosoma brucei brucei infection.
Topics: Acute-Phase Proteins; Animals; Anti-Bacterial Agents; Bacterial Infections; Carrier Proteins; Ciprof | 2009 |
Secondary bacterial infection in plasma endotoxin levels and the acute-phase response of mice infected with Trypanosoma brucei brucei.
Topics: Acute-Phase Reaction; Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Endotoxem | 2009 |